These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1443253)

  • 1. Side effects and the "blindability" of clinical drug trials.
    White K; Kando J; Park T; Waternaux C; Brown WA
    Am J Psychiatry; 1992 Dec; 149(12):1730-1. PubMed ID: 1443253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.
    Bystritsky A; Waikar SV
    J Nerv Ment Dis; 1994 Sep; 182(9):485-7. PubMed ID: 8083675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trazodone in depressed outpatients.
    Rickels K; Case WG
    Am J Psychiatry; 1982 Jun; 139(6):803-6. PubMed ID: 7044154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of two new antidepressants.
    Gershon S; Georgotas A; Newton R; Bush D
    Adv Biochem Psychopharmacol; 1982; 32():57-68. PubMed ID: 6211943
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of venlafaxine, trazodone, and placebo in major depression.
    Cunningham LA; Borison RL; Carman JS; Chouinard G; Crowder JE; Diamond BI; Fischer DE; Hearst E
    J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative trial of fluoxetine versus trazodone in outpatients with major depression.
    Perry PJ; Garvey MJ; Kelly MW; Cook BL; Dunner FJ; Winokur G
    J Clin Psychiatry; 1989 Aug; 50(8):290-4. PubMed ID: 2668259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changed plasma prolactin levels after etoperidone and placebo.
    Meco G; Casacchia M; Boni B; Cusimano G; Carta A; Iannuccelli M
    Int J Clin Pharmacol Res; 1984; 4(2):117-20. PubMed ID: 6469437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent experience with trazodone.
    Lader M
    Psychopathology; 1987; 20 Suppl 1():39-47. PubMed ID: 3321129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled study of trazodone in bulimia nervosa.
    Pope HG; Keck PE; McElroy SL; Hudson JI
    J Clin Psychopharmacol; 1989 Aug; 9(4):254-9. PubMed ID: 2671058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term therapy for depression with trazodone.
    Fabre LF; Feighner JP
    J Clin Psychiatry; 1983 Jan; 44(1):17-21. PubMed ID: 6337131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant properties of trazodone.
    Bryant SG; Ereshefsky L
    Clin Pharm; 1982; 1(5):406-17. PubMed ID: 6764164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of USA controlled trials of trazodone in clinical depression.
    Feighner JP; Boyer WF
    Psychopharmacology (Berl); 1988; 95 Suppl():S50-3. PubMed ID: 3133715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression.
    Amsterdam JD; Dunner DL; Fabre LF; Kiev A; Rush AJ; Goodman LI
    Pharmacopsychiatry; 1989 Jul; 22(4):137-43. PubMed ID: 2668978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable.
    Even C; Siobud-Dorocant E; Dardennes RM
    Br J Psychiatry; 2000 Jul; 177():47-51. PubMed ID: 10945088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodologic approach to adverse events applied to bupropion clinical trials.
    Cato AE; Cook L; Starbuck R; Heatherington D
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):187-90. PubMed ID: 6406455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of antidepressant trials using active and inert placebos.
    Moncrieff J
    Int J Methods Psychiatr Res; 2003; 12(3):117-27. PubMed ID: 12953139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.